SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-309976
Filing Date
2019-12-10
Accepted
2019-12-10 11:13:33
Documents
9
Period of Report
2019-12-10

Document Format Files

Seq Description Document Type Size
1 6-K d836094d6k.htm 6-K 15827
2 EX-99.1 d836094dex991.htm EX-99.1 77306
3 EX-99.2 d836094dex992.htm EX-99.2 15801
4 EX-99.3 d836094dex993.htm EX-99.3 20153
5 GRAPHIC g83609410.jpg GRAPHIC 292847
6 GRAPHIC g83609411.jpg GRAPHIC 260610
7 GRAPHIC g836094111.jpg GRAPHIC 44053
8 GRAPHIC g83609412.jpg GRAPHIC 229894
9 GRAPHIC g836094g1210164427784.jpg GRAPHIC 2530
  Complete submission text file 0001193125-19-309976.txt   1270072
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 191276807
SIC: 2834 Pharmaceutical Preparations